Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Thu, 28.09.2023
M1 Kliniken AG
First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG
(ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und erhöht das Kursziel von EUR 10,50 auf EUR 11,90.
Zusammenfassung:
Der Halbjahresbericht zeichnete sich durch ein besonders starkes Ergebnis
im Segment Beauty aus. Ange [ … ]
Wed, 27.09.2023
urban-gro, Inc
First Berlin Equity Research hat ein Research Update zu urban-gro, Inc.
(ISIN: US91704K2024) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und bestätigt sein Kursziel von USD 6,40.
Zusammenfassung:
Die Nachrichtenlage für urban-gro war in diesem Sommer ermutigend. Das
Unternehmen schloss in diesem Monat [ … ]
Tue, 26.09.2023
Schloss Wacheneheim AG
First Berlin Equity Research has published a research update on Schloss
Wachenheim AG (ISIN: DE0007229007). Analyst Simon Scholes reiterated his
BUY rating and maintained his EUR 22.00 price target.
Abstract:
Final results for the year ending 30 June showed a 10.9% increase in sales
to €425.8m (2021/22: €384.0m) and a 6.2% decline in [ … ]
Wed, 20.09.2023
Knaus Tabbert AG
First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG
(ISIN: DE000A2YN504) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und erhöht das Kursziel von EUR 83,00 auf EUR 86,00.
Zusammenfassung:
Das Management von Knaus Tabbert erhöhte die Prognose für 2023 aufgrund der
verbesserten [ … ]
Wed, 20.09.2023
Landi Renzo S.p.A.
FY 2023 will be a transition year; revenue development strong; earnings
development weak; unfavourable revenue mix weights; from 2025 onwards clear
winner of green energy transition; GBC estimates and price target adjusted;
BUY rating confirmed
Business development FY 2022
Based on the published business figures for the past financi [ … ]
Tue, 19.09.2023
Diversified Energy PLC
First Berlin Equity Research has published a research update on Diversified
Energy PLC (ISIN: GB00BYX7JT74). Analyst Simon Scholes reiterated his BUY
rating and maintained his GBp 180.00 price target.
Abstract:
H1/23 results once again demonstrated the effectiveness of DEC's business
model in delivering high profits irrespective of the level of [ … ]
Mon, 18.09.2023
PAION AG
First Berlin Equity Research has published a research update on PAION AG
(ISIN: DE000A0B65S3). Analyst Simon Scholes reiterated his BUY rating and
decreased the price target from EUR 38.00 to EUR 11.00.
Abstract:
PAION's lead product remimazolam was first approved in January 2020 in
Japan in the indication general anesthesia (GA). It has since [ … ]
Mon, 18.09.2023
Haemato AG
First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN:
DE000A289VV1) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und erhöht das Kursziel von EUR 33,00 auf EUR 34,00.
Zusammenfassung:
Das Sechsmonatsbericht lag nahe an unseren Prognosen und verdeutlichte die
schlankere operative Kostenstr [ … ]
Thu, 14.09.2023
HAEMATO AG
H1 2023: Turnover and EBIT above our expectations; forecasts and target
price slightly raised; BUY rating confirmed
In the first half of 2023, HAEMATO AG achieved a revenue increase of 10.5 %
to € 133.64 million (previous year: € 120.97 million) and thus exceeded our
expectations. This sales development, which is separated accord [ … ]
Thu, 14.09.2023
Vectron Systems AG
H1 2023: 'On track': Turnover in line with expectations; EBITDA climbs
significantly; GBC-Forecasts raised; Target price raised to €10.00
(previously: €9.40); Rating: BUY
The first six months of 2023 were marked by the consolidation of acardo
group AG, which was acquired on 1st January 2023. acardo sales, which were
consolidated [ … ]
